AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32089450 — intervention group
Group type: EXPERIMENTAL
Intervention: vHIT
Number of subjects: 22
Study 32089450 — intervention group
Group type: EXPERIMENTAL
Intervention: SHIMP test
Number of subjects: 22
Study 36301511 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous caffeine (20 mg/kg)
Number of subjects: 38
Study 36301511 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral caffeine (20 mg/kg)
Number of subjects: 38
Study 36301511 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous caffeine (5 mg/kg second dose)
Number of subjects: 38
Study 36301511 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral caffeine (5 mg/kg second dose)
Number of subjects: 38
Study 35565828 — intervention group
Group type: EXPERIMENTAL
Intervention: Mg-Teadiola (combination of magnesium, vitamins B6, B9, B12, rhodiola, and green tea/L-theanine)
Number of subjects: 100
Study 35565828 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 35565828 — intervention group
Group type: EXPERIMENTAL
Intervention: Mg-Teadiola
Number of subjects: 100
Study 615916192 — intervention group
Group type: EXPERIMENTAL
Intervention: Monocular perimetry
Number of subjects: 11
Study 615916192 — intervention group
Group type: EXPERIMENTAL
Intervention: Binocular perimetry
Number of subjects: 11
Study 615916192 — intervention group
Group type: COMPARATOR
Intervention: Both monocular and binocular perimetry
Number of subjects: 11
Study 35126882 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy (NET)
Number of subjects: 33
Study 35126882 — intervention group
Group type: COMPARATOR
Intervention: Present-Centered Therapy (PCT)
Number of subjects: 33
Study 35126882 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 33
Study 33639003 — intervention group
Group type: EXPERIMENTAL
Intervention: Full Skin Examination (FSE)
Number of subjects: 763
Study 33639003 — intervention group
Group type: COMPARATOR
Intervention: Targeted Lesion Examination (TLE)
Number of subjects: 763
Study 33136072 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training (RAGT)
Number of subjects: 47
Study 33136072 — intervention group
Group type: COMPARATOR
Intervention: Conventional kinesiotherapy (CON)
Number of subjects: 47
Study 34265578 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture (5 sessions)
Number of subjects: 44
Study 34265578 — intervention group
Group type: COMPARATOR
Intervention: Control (no therapy)
Number of subjects: 44
Study 32143147 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional binding immunoassay methods (specifically FXIIa-binding method)
Number of subjects: 65
Study 32143147 — intervention group
Group type: COMPARATOR
Intervention: Conventional chromogenic assay
Number of subjects: 65
Study 32143147 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoassays based on functional binding to activated complement C1s or Factor XIIa/kallikrein
Number of subjects: 65
Study 32022261 — intervention group
Group type: EXPERIMENTAL
Intervention: APG-157 (100 mg or 200 mg, delivered transorally every hour for 3 hours)
Number of subjects: 25
Study 32022261 — intervention group
Group type: EXPERIMENTAL
Intervention: APG-157
Number of subjects: 25
Study 35199968 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 170
Study 35199968 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 170
Study 33105387 — intervention group
Group type: EXPERIMENTAL
Intervention: LOW steps (2675 ± 314 steps per day)
Number of subjects: 10
Study 33105387 — intervention group
Group type: EXPERIMENTAL
Intervention: LIMITED steps (4759 ± 276 steps per day)
Number of subjects: 10
Study 33105387 — intervention group
Group type: COMPARATOR
Intervention: NORMAL steps (8481 ± 581 steps per day)
Number of subjects: 10
Study 33320035 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic Syndrome (MetS)
Number of subjects: 815
Study 33320035 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 815
Study 33320035 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyslipidaemia
Number of subjects: 815
Study 33320035 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes mellitus
Number of subjects: 815
Study 33320035 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary heart disease
Number of subjects: 815
Study 34896732 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-hour diaper changes
Number of subjects: 46
Study 34896732 — intervention group
Group type: COMPARATOR
Intervention: 6-hour diaper changes
Number of subjects: 46
Study 34896732 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaper change during BCEs
Number of subjects: 46
Study 34896732 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants awake at the beginning of BCEs
Number of subjects: 46
Study 34112734 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2016
Study 34112734 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline blood eosinophil counts ≥300 cells·μL‐1 and FENO ≥50 ppb
Number of subjects: 2016
Study 34112734 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent eosinophil and FENO elevations
Number of subjects: 2016
Study 34112734 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of eosinophils and FENO
Number of subjects: 2016
Study 34112734 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline characteristics (exacerbation history, corticosteroid use, nasal polyposis, Asian race, geographic region)
Number of subjects: 2016
Study 33107924 — intervention group
Group type: EXPERIMENTAL
Intervention: Out-of-hospital tranexamic acid
Number of subjects: 31
Study 33107924 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 36494716 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group GPs trained in the use of a patient education booklet during low back pain patient visits.
Number of subjects: 19
Study 36494716 — intervention group
Group type: COMPARATOR
Intervention: Control group GPs providing usual care.
Number of subjects: 19
Study 32241373 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-month educational intervention (the SI! Program)
Number of subjects: 1216
Study 32241373 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1216
Study 35854391 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula oxygen therapy (HFNC)
Number of subjects: 562
Study 35854391 — intervention group
Group type: COMPARATOR
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 562
Study 33682773 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory and core-postural stabilisation
Number of subjects: 14
Study 33682773 — intervention group
Group type: COMPARATOR
Intervention: Abdominal breathing
Number of subjects: 14
Study 34483640 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest postoperative pre-albumin < 15 mg/dL
Number of subjects: 436
Study 33050362 — intervention group
Group type: EXPERIMENTAL
Intervention: HBOT treatment after exercise in NN conditions (HNN group)
Number of subjects: 18
Study 33050362 — intervention group
Group type: EXPERIMENTAL
Intervention: HBOT treatment after exercise in HH conditions (HHH group)
Number of subjects: 18
Study 33050362 — intervention group
Group type: COMPARATOR
Intervention: Exercise in NN conditions (NN group)
Number of subjects: 18
Study 616871163 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise (at least 30 min per day, 5 times weekly)
Number of subjects: 100
Study 616871163 — intervention group
Group type: COMPARATOR
Intervention: Control group (recommended exercise of the same intensity but not mandatory)
Number of subjects: 100
Study 616871163 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise
Number of subjects: 100
Study 616871163 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 35818787 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Cognitive Therapy (MBCT)
Number of subjects: 20
Study 35818787 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 20
Study 34625284 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg/day
Number of subjects: 39
Study 36322059 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-reported data
Number of subjects: 15076
Study 36322059 — intervention group
Group type: COMPARATOR
Intervention: Electronic health record data
Number of subjects: 15076
Study 36322059 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient report of clinical endpoints
Number of subjects: 15076
Study 36322059 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary revascularization
Number of subjects: 15076
Study 34340880 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% citric acid spray
Number of subjects: 112
Study 34340880 — intervention group
Group type: COMPARATOR
Intervention: Cool water spray
Number of subjects: 112
Study 35220330 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release (SR) pregabalin (150 to 600 mg/d) once daily for 12 weeks
Number of subjects: 371
Study 35220330 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release (IR) pregabalin (150 to 600 mg/d) twice daily for 12 weeks
Number of subjects: 371
Study 35220330 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release (SR) pregabalin
Number of subjects: 371
Study 35220330 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SR and IR pregabalin
Number of subjects: 371
Study 32059724 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored support recommendations (n=171 caregivers)
Number of subjects: 226
Study 32059724 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendations concerning mental health
Number of subjects: 226
Study 32059724 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendations concerning physical health
Number of subjects: 226
Study 32059724 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendations concerning social, legal, and financial affairs
Number of subjects: 226
Study 32059724 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendations concerning social integration (especially caregiver supporting groups)
Number of subjects: 226
Study 32059724 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver supporting groups
Number of subjects: 226
Study 32059724 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional status of the PwD
Number of subjects: 226
Study 32059724 — intervention group
Group type: EXPERIMENTAL
Intervention: Activities of daily living abilities of the PwD
Number of subjects: 226
Study 32059724 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognition and depression status of the PwD
Number of subjects: 226
Study 32059724 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical and mental health of family dementia caregivers
Number of subjects: 226
Study 34226214 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced occupational therapy discharge planning intervention (the HOME programme) including pre and postdischarge home visits, goal setting, and occupational therapy in the home.
Number of subjects: 360
Study 34226214 — intervention group
Group type: COMPARATOR
Intervention: Standardised discharge planning intervention (control group).
Number of subjects: 360
Study 32325078 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular repetition schedule of musical patterns
Number of subjects: 0
Study 32325078 — intervention group
Group type: COMPARATOR
Intervention: Irregular repetition schedule of musical patterns
Number of subjects: 0
Study 35370039 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months of adjuvant doublet chemotherapy (CAPOX)
Number of subjects: 2310
Study 35370039 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months of adjuvant doublet chemotherapy
Number of subjects: 2310
Study 33831698 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling (DN) to the thoracolumbar junction multifidi
Number of subjects: 54
Study 33831698 — intervention group
Group type: COMPARATOR
Intervention: Sham dry needling (sham DN) to the thoracolumbar junction multifidi
Number of subjects: 54
Study 33831698 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling (DN)
Number of subjects: 54
Study 33831698 — intervention group
Group type: COMPARATOR
Intervention: Sham dry needling (sham DN)
Number of subjects: 54
Study 32711551 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 8107
Study 32711551 — intervention group
Group type: COMPARATOR
Intervention: Clinician-recorded times
Number of subjects: 8107
Study 32711551 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitored times
Number of subjects: 8107
Study 32058362 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-SET
Number of subjects: 35
Study 32058362 — intervention group
Group type: EXPERIMENTAL
Intervention: 18-SET
Number of subjects: 35
Study 32058362 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-SET
Number of subjects: 35
Study 33336381 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumetanide (diuretic agent)
Number of subjects: 6
Study 34051017 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency Department (ED) attendance with lower urgency problems
Number of subjects: 400
Study 32278674 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab plus VMP (D-VMP)
Number of subjects: 0
Study 32278674 — intervention group
Group type: COMPARATOR
Intervention: VMP
Number of subjects: 0
Study 32278674 — intervention group
Group type: COMPARATOR
Intervention: ALCYONE VMP
Number of subjects: 0
Study 32278674 — intervention group
Group type: EXPERIMENTAL
Intervention: ALCYONE D-VMP
Number of subjects: 0
Study 35777873 — intervention group
Group type: EXPERIMENTAL
Intervention: Med Safety mobile application training for healthcare professionals
Number of subjects: 382
Study 35777873 — intervention group
Group type: COMPARATOR
Intervention: Paper-based and web-based reporting training
Number of subjects: 382
Study 33756023 — intervention group
Group type: EXPERIMENTAL
Intervention: High-demand 'working memory' task
Number of subjects: 57
Study 33756023 — intervention group
Group type: COMPARATOR
Intervention: Low-demand 'motor control' task
Number of subjects: 57
Study 35609163 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 text message reminder (sent 2 business days prior to the appointment)
Number of subjects: 158669
Study 35609163 — intervention group
Group type: COMPARATOR
Intervention: 2 text message reminders (sent 2 and 3 days prior)
Number of subjects: 158669
Study 34037753 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 0
Study 34037753 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 34133004 — intervention group
Group type: EXPERIMENTAL
Intervention: Truthful responding condition
Number of subjects: 1502
Study 34133004 — intervention group
Group type: COMPARATOR
Intervention: Binge Eating Disorder (BED) condition
Number of subjects: 1502
Study 34133004 — intervention group
Group type: COMPARATOR
Intervention: Anorexia Nervosa (AN) condition
Number of subjects: 1502
Study 34133004 — intervention group
Group type: COMPARATOR
Intervention: Bulimia Nervosa (BN) condition
Number of subjects: 1502
Study 34133004 — intervention group
Group type: EXPERIMENTAL
Intervention: General UDEBS scores
Number of subjects: 1502
Study 34133004 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender analysis
Number of subjects: 1502
Study 34623899 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery only (Arm A)
Number of subjects: 138
Study 34623899 — intervention group
Group type: EXPERIMENTAL
Intervention: 55.8 Gy radiotherapy (Arm B)
Number of subjects: 138
Study 34623899 — intervention group
Group type: EXPERIMENTAL
Intervention: Ifosfamide and doxorubicin chemotherapy plus 55.8 Gy RT (Arm C)
Number of subjects: 138
Study 34623899 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant ifosfamide and 45 Gy RT, then surgery and RT boost (Arm D)
Number of subjects: 138
Study 35510727 — intervention group
Group type: EXPERIMENTAL
Intervention: Epilepsy group
Number of subjects: 56
Study 35510727 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study 35510727 — intervention group
Group type: EXPERIMENTAL
Intervention: Epilepsy group with comorbid psychiatric diseases
Number of subjects: 56
Study 35510727 — intervention group
Group type: EXPERIMENTAL
Intervention: Epilepsy group using psychiatric drugs
Number of subjects: 56
Study 35510727 — intervention group
Group type: EXPERIMENTAL
Intervention: Epilepsy group (girls)
Number of subjects: 56
Study 32804843 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigational product (liquid sachets containing hyaluronic acid, amino acids, and rice extract)
Number of subjects: 40
Study 32804843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 35752301 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical management with misoprostol (800 μg sublingually)
Number of subjects: 131
Study 35752301 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 131
Study 33059765 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated short‐term fasting with a maximum energy supply of 350–400 kcal on fasting days
Number of subjects: 150
Study 33059765 — intervention group
Group type: COMPARATOR
Intervention: Repeated short‐term normocaloric plant‐based diet with restriction of refined carbohydrates
Number of subjects: 150
Study 33059765 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated short‐term fasting
Number of subjects: 150
Study 33720329 — intervention group
Group type: EXPERIMENTAL
Intervention: VIPP-SD (Video‐feedback Intervention to promote Positive Parenting and Sensitive Discipline)
Number of subjects: 300
Study 33720329 — intervention group
Group type: EXPERIMENTAL
Intervention: VIPP-SD
Number of subjects: 300
Study 33720329 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study 36414990 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular overdentures retained by 4 interforaminal implants (Test)
Number of subjects: 20
Study 36414990 — intervention group
Group type: COMPARATOR
Intervention: Mandibular overdentures retained by 2 interforaminal implants (Control)
Number of subjects: 20
Study 32389326 — intervention group
Group type: EXPERIMENTAL
Intervention: Contezolid (MRX-I) 600 mg BID for 14 days under fed conditions
Number of subjects: 0
Study 32389326 — intervention group
Group type: EXPERIMENTAL
Intervention: Contezolid (MRX-I) 800 mg BID for 14 days under fed conditions
Number of subjects: 0
Study 32389326 — intervention group
Group type: EXPERIMENTAL
Intervention: Contezolid (MRX-I) 800 mg BID for 7-14 days under fed conditions
Number of subjects: 0
Study 34922353 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 18109
Study 34922353 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18109
Study 33606713 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (20,000 IU for <6 months, 50,000 IU for 6-12 months, 100,000 IU for 13-59 months on the first day, followed by 10,000 IU maintenance for next 4 days)
Number of subjects: 197
Study 33606713 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 197
Study 33606713 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study 36073727 — intervention group
Group type: EXPERIMENTAL
Intervention: HoloLens2™ enhanced remote case-based teaching
Number of subjects: 56
Study 36073727 — intervention group
Group type: COMPARATOR
Intervention: Conventional remote case-based teaching
Number of subjects: 56
Study 33615976 — intervention group
Group type: EXPERIMENTAL
Intervention: Below-elbow cast (BEC)
Number of subjects: 51
Study 33615976 — intervention group
Group type: COMPARATOR
Intervention: Above-elbow cast (AEC)
Number of subjects: 51
Study 35867073 — intervention group
Group type: EXPERIMENTAL
Intervention: Normoxia moderate (NM)
Number of subjects: 28
Study 35867073 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia moderate (HM)
Number of subjects: 28
Study 35867073 — intervention group
Group type: EXPERIMENTAL
Intervention: Normoxia intensive (NI)
Number of subjects: 28
Study 35867073 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia intensive (HI)
Number of subjects: 28
Study 33905606 — intervention group
Group type: EXPERIMENTAL
Intervention: IVC clamping
Number of subjects: 120
Study 33905606 — intervention group
Group type: COMPARATOR
Intervention: Non-IVC clamping
Number of subjects: 120
Study 34974527 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab plus lenalidomide/dexamethasone (D‐Rd)
Number of subjects: 737
Study 33298040 — intervention group
Group type: EXPERIMENTAL
Intervention: MF + CBL model
Number of subjects: 104
Study 33298040 — intervention group
Group type: COMPARATOR
Intervention: LBL model
Number of subjects: 104
Study 35191384 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal ulnar nerve anesthesia
Number of subjects: 60
Study 35191384 — intervention group
Group type: COMPARATOR
Intervention: Distal ulnar nerve anesthesia
Number of subjects: 60
Study 33231317 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulated social status using a false feedback paradigm in Study 2
Number of subjects: 0
Study 33231317 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulated meritocracy using a scrambled sentence task in Study 3
Number of subjects: 0
Study 32234041 — intervention group
Group type: EXPERIMENTAL
Intervention: SAFMEDS intervention group (n=13)
Number of subjects: 27
Study 32234041 — intervention group
Group type: COMPARATOR
Intervention: Usual teaching control group (n=14)
Number of subjects: 27
Study 33896930 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel drug-coated balloons (Pantera Lux)
Number of subjects: 199
Study 35660972 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesothelioma risk score (MRS) based on SII and haemoglobin levels
Number of subjects: 144
Study 35660972 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesothelioma risk score (MRS)
Number of subjects: 144
Study 34175866 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed‐incision negative‐pressure therapy (ciNPT)
Number of subjects: 148
Study 34175866 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgical dressing (control)
Number of subjects: 148
Study 35858590 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus chemotherapy
Number of subjects: 0
Study 34146251 — intervention group
Group type: EXPERIMENTAL
Intervention: NiTi systems (Reciproc® Blue)
Number of subjects: 57
Study 34146251 — intervention group
Group type: EXPERIMENTAL
Intervention: NiTi systems (MTwo®)
Number of subjects: 57